Application 211988

Type
NDA
Sponsor
Heron Therapeutics, Inc.

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001Zynrelefbupivacaine and meloxicamSOLUTION;INJECTION60MG/1.8MGNoNo
002Zynrelefbupivacaine and meloxicamSOLUTION; INJECTION200MG/6MGNoNo
003Zynrelefbupivacaine and meloxicamSOLUTION; INJECTION300MG/9MGNoNo
004Zynrelefbupivacaine and meloxicamSOLUTION; INJECTION400MG/12MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
47426-301ZYNRELEFBUPIVACAINE and MELOXICAMHeron Therapeutics, Inc.NDACurrent
47426-301ZYNRELEFBUPIVACAINE and MELOXICAMHeron Therapeutics, Inc.NDACurrent
47426-301ZYNRELEFBUPIVACAINE and MELOXICAMHeron Therapeutics, Inc.NDACurrent
47426-302ZYNRELEFBUPIVACAINE and MELOXICAMHeron Therapeutics, Inc.NDACurrent
47426-302ZYNRELEFBUPIVACAINE and MELOXICAMHeron Therapeutics, Inc.NDACurrent
47426-302ZYNRELEFBUPIVACAINE and MELOXICAMHeron Therapeutics, Inc.NDACurrent
47426-303ZYNRELEFBUPIVACAINE and MELOXICAMHeron Therapeutics, Inc.NDACurrent
47426-303ZYNRELEFBUPIVACAINE and MELOXICAMHeron Therapeutics, Inc.NDACurrent
47426-303ZYNRELEFBUPIVACAINE and MELOXICAMHeron Therapeutics, Inc.NDACurrent
47426-304ZYNRELEFBUPIVACAINE and MELOXICAMHeron Therapeutics, Inc.NDACurrent
47426-304ZYNRELEFBUPIVACAINE and MELOXICAMHeron Therapeutics, Inc.NDACurrent
47426-304ZYNRELEFBUPIVACAINE and MELOXICAMHeron Therapeutics, Inc.NDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
85651SUPPL 2026-04-07
85650SUPPL 2026-04-07
80401SUPPL 2024-11-25
80318SUPPL 2024-11-22
77885SUPPL 2024-03-21
77297SUPPL 2024-01-25
77284SUPPL 2024-01-24
71469SUPPL2022-06-28
70687ORIG2022-04-05
69526SUPPL2021-12-10
69520SUPPL2021-12-09
67484ORIG2021-05-13
67481ORIG2021-05-13